New hepatitis d drug tested for preventing deadly liver complications

This study investigates whether a new antiviral drug called Bulevirtide can reduce dangerous high pressure in the liver (portal hypertension) in people with both hepatitis B and hepatitis D infections who also have liver scarring (cirrhosis). Researchers are measuring pressure changes in the liver before and after treatment to see if controlling the virus helps control this serious complication. The goal is to see if this treatment can prevent life-threatening issues like internal bleeding and fluid buildup.